Stocktoria
Enveric Biosciences, Inc. ENVB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2009-07-21
Enveric Biosciences, Inc. statistics & valuation
Market cap$5.2M
P / B1.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -172.1% | -310.6% | -402.1% | -94.5% | -183.3% |
| Return on equity | -210.0% | -601.1% | -883.9% | -125.9% | -219.6% |
| Current ratio | 5.38 | 1.84 | 1.53 | 4.61 | 6.48 |
Source: SEC EDGAR filings · CIK 0000890821 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.